<?xml version="1.0" ?>
<ns0:MeasureDoc xmlns:html="http://www.w3.org/1999/xhtml" xmlns:ns0="http://lc.ca.gov/legalservices/schemas/caml.1#" xmlns:ns3="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" version="1.0" xsi:schemaLocation="http://lc.ca.gov/legalservices/schemas/caml.1# xca.1.xsd">
	


	<ns0:Description>
		<ns0:Id>20250AB__096896AMD</ns0:Id>
		<ns0:VersionNum>96</ns0:VersionNum>
		<ns0:History>
			<ns0:Action>
				<ns0:ActionText>INTRODUCED</ns0:ActionText>
				<ns0:ActionDate>2025-02-20</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>AMENDED_ASSEMBLY</ns0:ActionText>
				<ns0:ActionDate>2025-04-07</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>AMENDED_SENATE</ns0:ActionText>
				<ns0:ActionDate>2025-06-09</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>AMENDED_SENATE</ns0:ActionText>
				<ns0:ActionDate>2025-07-09</ns0:ActionDate>
			</ns0:Action>
		</ns0:History>
		<ns0:LegislativeInfo>
			<ns0:SessionYear>2025</ns0:SessionYear>
			<ns0:SessionNum>0</ns0:SessionNum>
			<ns0:MeasureType>AB</ns0:MeasureType>
			<ns0:MeasureNum>968</ns0:MeasureNum>
			<ns0:MeasureState>AMD</ns0:MeasureState>
		</ns0:LegislativeInfo>
		<ns0:AuthorText authorType="LEAD_AUTHOR">Introduced by Assembly Member Boerner</ns0:AuthorText>
		<ns0:Authors>
			<ns0:Legislator>
				<ns0:Contribution>LEAD_AUTHOR</ns0:Contribution>
				<ns0:House>ASSEMBLY</ns0:House>
				<ns0:Name>Boerner</ns0:Name>
			</ns0:Legislator>
		</ns0:Authors>
		<ns0:Title>An act to amend Sections 2242.2, 4052.3, and 4064.5 of the Business and Professions Code, relating to healing arts.</ns0:Title>
		<ns0:RelatingClause>healing arts</ns0:RelatingClause>
		<ns0:GeneralSubject>
			<ns0:Subject>Contraceptives.</ns0:Subject>
		</ns0:GeneralSubject>
		<ns0:DigestText>
			<html:p>Existing law, the Pharmacy Law, establishes, in the Department of Consumer Affairs, the California State Board of Pharmacy to license and regulate the practice of pharmacy.</html:p>
			<html:p>Existing law authorizes a physician and surgeon, nurse practitioner, registered nurse, and specified other health care practitioners acting within the scope of their practice to use a self-screening tool to identify patient risk factors for the use of self-administered hormonal contraceptives by a patient and, after examination, to prescribe, furnish, or dispense self-administered hormonal contraceptives to the patient.</html:p>
			<html:p>This bill would, instead, make those provisions applicable to contraceptives.</html:p>
			<html:p>Existing law authorizes a pharmacist to furnish self-administered hormonal contraceptives in accordance with standardized procedures or protocols developed and approved by both the California State Board of Pharmacy and the Medical Board of California, in consultation with specified other entities.</html:p>
			<html:p>This bill would authorize a pharmacist to also furnish
			 federal Food and Drug Administration-approved nonhormonal contraceptives in accordance with those standardized procedures or protocols. The bill would require a pharmacist, for each federal Food and Drug Administration-approved nonhormonal contraceptives initiated, to provide the recipient with a standardized fact sheet, as specified.</html:p>
			<html:p>Existing law prohibits a pharmacist, pharmacist’s employer, or pharmacist’s agent from directly charging a patient a separate consultation fee for emergency contraception drug therapy services and requires the pharmacist to disclose the total retail price of the emergency
			 contraception drug therapy. Existing law makes those provisions inoperative for dedicated emergency contraception drugs if these drugs are reclassified as over-the-counter products by the federal Food and Drug Administration.</html:p>
			<html:p>This bill would delete those provisions.</html:p>
			<html:p>Existing law requires a pharmacist to dispense, at a patient’s request, up to a 12-month supply of an FDA-approved, self-administered hormonal contraceptive.</html:p>
			<html:p>This bill would, instead, make those provisions applicable to contraceptives.</html:p>
			<html:p>This bill would make related conforming changes.</html:p>
		</ns0:DigestText>
		<ns0:DigestKey>
			<ns0:VoteRequired>MAJORITY</ns0:VoteRequired>
			<ns0:Appropriation>NO</ns0:Appropriation>
			<ns0:FiscalCommittee>YES</ns0:FiscalCommittee>
			<ns0:LocalProgram>NO</ns0:LocalProgram>
		</ns0:DigestKey>
		<ns0:MeasureIndicators>
			<ns0:ImmediateEffect>NO</ns0:ImmediateEffect>
			<ns0:ImmediateEffectFlags>
				<ns0:Urgency>NO</ns0:Urgency>
				<ns0:TaxLevy>NO</ns0:TaxLevy>
				<ns0:Election>NO</ns0:Election>
				<ns0:UsualCurrentExpenses>NO</ns0:UsualCurrentExpenses>
				<ns0:BudgetBill>NO</ns0:BudgetBill>
				<ns0:Prop25TrailerBill>NO</ns0:Prop25TrailerBill>
			</ns0:ImmediateEffectFlags>
		</ns0:MeasureIndicators>
	</ns0:Description>
	<ns0:Bill id="bill">
		<ns0:Preamble>The people of the State of California do enact as follows:</ns0:Preamble>
		<ns0:BillSection id="id_A8170C18-EE39-42E0-8F99-E74146AC00BF">
			<ns0:Num>SECTION 1.</ns0:Num>
			<ns0:ActionLine action="IS_AMENDED" ns3:href="urn:caml:codes:BPC:caml#xpointer(%2Fcaml%3ALawDoc%2Fcaml%3ACode%2Fcaml%3ALawHeading%5B%40type%3D'DIVISION'%20and%20caml%3ANum%3D'2.'%5D%2Fcaml%3ALawHeading%5B%40type%3D'CHAPTER'%20and%20caml%3ANum%3D'5.'%5D%2Fcaml%3ALawHeading%5B%40type%3D'ARTICLE'%20and%20caml%3ANum%3D'12.'%5D%2Fcaml%3ALawSection%5Bcaml%3ANum%3D'2242.2.'%5D)" ns3:label="fractionType: LAW_SECTION" ns3:type="locator">
				Section 2242.2 of the 
				<ns0:DocName>Business and Professions Code</ns0:DocName>
				 is amended to read:
			</ns0:ActionLine>
			<ns0:Fragment>
				<ns0:LawSection id="id_52BD80DB-2627-4672-8259-74A83CCEE353">
					<ns0:Num>2242.2.</ns0:Num>
					<ns0:LawSectionVersion id="id_0C24DB1C-D5CE-49BE-AD1D-626C3D829F5C">
						<ns0:Content>
							<html:p>Notwithstanding any other law, a physician and surgeon, a nurse practitioner acting within the scope of Section 2837.103 or 2837.104, a registered nurse acting in accordance with Section 2725.2, a certified nurse-midwife acting within the scope of Section 2746.51, a nurse practitioner acting within the scope of Section 2836.1, a physician assistant acting within the scope of Section 3502.1, and a pharmacist acting within the scope of Section 4052.3 may use a self-screening tool that will identify patient risk factors for the use of contraceptives by a patient, and, after an appropriate prior examination, prescribe, furnish, or dispense, as applicable, contraceptives to the patient. Blood pressure, weight, height, and patient health history may be
						self-reported using the self-screening tool that identifies patient risk factors.</html:p>
						</ns0:Content>
					</ns0:LawSectionVersion>
				</ns0:LawSection>
			</ns0:Fragment>
		</ns0:BillSection>
		<ns0:BillSection id="id_41178A5D-831A-4455-AF77-2924892E61DB">
			<ns0:Num>SEC. 2.</ns0:Num>
			<ns0:ActionLine action="IS_AMENDED" ns3:href="urn:caml:codes:BPC:caml#xpointer(%2Fcaml%3ALawDoc%2Fcaml%3ACode%2Fcaml%3ALawHeading%5B%40type%3D'DIVISION'%20and%20caml%3ANum%3D'2.'%5D%2Fcaml%3ALawHeading%5B%40type%3D'CHAPTER'%20and%20caml%3ANum%3D'9.'%5D%2Fcaml%3ALawHeading%5B%40type%3D'ARTICLE'%20and%20caml%3ANum%3D'3.'%5D%2Fcaml%3ALawSection%5Bcaml%3ANum%3D'4052.3.'%5D)" ns3:label="fractionType: LAW_SECTION" ns3:type="locator">
				Section 4052.3 of the 
				<ns0:DocName>Business and Professions Code</ns0:DocName>
				 is amended to read:
			</ns0:ActionLine>
			<ns0:Fragment>
				<ns0:LawSection id="id_5F8E6E9D-9106-476B-BF5E-97B8759ED5CA">
					<ns0:Num>4052.3.</ns0:Num>
					<ns0:LawSectionVersion id="id_02EA7FD9-9143-40E7-A194-8E034F65BADD">
						<ns0:Content>
							<html:p>
								(a)
								<html:span class="EnSpace"/>
								(1)
								<html:span class="EnSpace"/>
								Notwithstanding any other law, a pharmacist may furnish  self-administered hormonal or federal Food and Drug Administration-approved nonhormonal  contraceptives in accordance with standardized procedures or protocols developed and approved by both the board and the Medical Board of California in consultation with the American Congress of Obstetricians and Gynecologists, the California Pharmacists Association, and other appropriate entities. The standardized procedure or protocol shall require that the patient use a
						self-screening tool that will identify patient risk factors for use of prescription-only contraceptives, based on the most recent United States Medical Eligibility Criteria (USMEC) for Contraceptive Use developed by the federal Centers for Disease Control and Prevention, and that the pharmacist refer the patient to the patient’s primary care provider or, if the patient does not have a primary care provider, to nearby clinics, upon furnishing a
						prescription-only contraceptive pursuant to this subdivision, or if it is determined that use of a contraceptive is not recommended.
							</html:p>
							<html:p>
								(2)
								<html:span class="EnSpace"/>
								The board and the Medical Board of California are both authorized to ensure compliance with this subdivision, and each board is specifically charged with the enforcement of this subdivision with respect to its respective licensees. This subdivision does not expand the authority of a pharmacist to prescribe any prescription medication.
							</html:p>
							<html:p>
								(b)
								<html:span class="EnSpace"/>
								(1)
								<html:span class="EnSpace"/>
								Notwithstanding any other law, a pharmacist may furnish emergency contraception in accordance with either of the following:
							</html:p>
							<html:p>
								(A)
								<html:span class="EnSpace"/>
								Standardized procedures or protocols developed by the pharmacist and an
						authorized prescriber who is acting within their scope of practice.
							</html:p>
							<html:p>
								(B)
								<html:span class="EnSpace"/>
								Standardized procedures or protocols developed and approved by both the board and the Medical Board of California in consultation with the American Congress of Obstetricians and Gynecologists, the California Pharmacists Association, and other appropriate entities. The board and the Medical Board of California are both authorized to ensure compliance with this subparagraph, and each board is specifically charged with the enforcement of this provision with respect to its respective licensees. This subdivision does not expand the authority of a pharmacist to prescribe any prescription medication.
							</html:p>
							<html:p>
								(2)
								<html:span class="EnSpace"/>
								Prior to performing a procedure authorized under this subdivision, a pharmacist shall complete a training
						program on emergency contraception that consists of at least one hour of approved continuing education on emergency contraception drug therapy. 
							</html:p>
							<html:p>
								(3)
								<html:span class="EnSpace"/>
								A pharmacist shall not require a patient to provide individually identifiable medical information that is not specified in Section 1707.1 of Title 16 of the California Code of Regulations before initiating emergency contraception drug therapy pursuant to this subdivision.
							</html:p>
							<html:p>
								(c)
								<html:span class="EnSpace"/>
								For each emergency contraception drug therapy or self-administered hormonal or federal Food and Drug Administration-approved nonhormonal contraception initiated pursuant to this section, the pharmacist shall provide the recipient with a standardized factsheet that includes, but is not limited to, the indications and contraindications for use, the appropriate method for use, the need for medical followup, and other appropriate information. The board shall develop this form in consultation with the State Department of Public Health, the American Congress of
						Obstetricians and Gynecologists, the California Pharmacists Association, and other health care organizations. This section does not preclude the use of existing publications developed by nationally recognized medical organizations.
							</html:p>
						</ns0:Content>
					</ns0:LawSectionVersion>
				</ns0:LawSection>
			</ns0:Fragment>
		</ns0:BillSection>
		<ns0:BillSection id="id_D96A033E-6CE1-4D4D-B4D9-1C93DBE2EC39">
			<ns0:Num>SEC. 3.</ns0:Num>
			<ns0:ActionLine action="IS_AMENDED" ns3:href="urn:caml:codes:BPC:caml#xpointer(%2Fcaml%3ALawDoc%2Fcaml%3ACode%2Fcaml%3ALawHeading%5B%40type%3D'DIVISION'%20and%20caml%3ANum%3D'2.'%5D%2Fcaml%3ALawHeading%5B%40type%3D'CHAPTER'%20and%20caml%3ANum%3D'9.'%5D%2Fcaml%3ALawHeading%5B%40type%3D'ARTICLE'%20and%20caml%3ANum%3D'3.'%5D%2Fcaml%3ALawSection%5Bcaml%3ANum%3D'4064.5.'%5D)" ns3:label="fractionType: LAW_SECTION" ns3:type="locator">
				Section 4064.5 of the 
				<ns0:DocName>Business and Professions Code</ns0:DocName>
				 is amended to read:
			</ns0:ActionLine>
			<ns0:Fragment>
				<ns0:LawSection id="id_EB1C1269-C787-4026-97EB-1DA86FF45A86">
					<ns0:Num>4064.5.</ns0:Num>
					<ns0:LawSectionVersion id="id_688EA89F-0332-40BF-AD75-25315F502CE5">
						<ns0:Content>
							<html:p>
								(a)
								<html:span class="EnSpace"/>
								A pharmacist may dispense not more than a 90-day supply of a dangerous drug other than a controlled substance pursuant to a valid prescription that specifies an initial quantity of less than a 90-day supply followed by periodic refills of that amount if all of the following requirements are satisfied:
							</html:p>
							<html:p>
								(1)
								<html:span class="EnSpace"/>
								The patient has completed an initial 30-day supply of the dangerous drug.
							</html:p>
							<html:p>
								(2)
								<html:span class="EnSpace"/>
								The total quantity of dosage units dispensed does not exceed the total quantity of dosage units authorized by the prescriber on the prescription, including refills.
							</html:p>
							<html:p>
								(3)
								<html:span class="EnSpace"/>
								The
						prescriber has not specified on the prescription that dispensing the prescription in an initial amount followed by periodic refills is medically necessary.
							</html:p>
							<html:p>
								(4)
								<html:span class="EnSpace"/>
								The pharmacist is exercising their professional judgment.
							</html:p>
							<html:p>
								(b)
								<html:span class="EnSpace"/>
								For purposes of this section, if the prescription continues the same medication as previously dispensed in a 90-day supply, the initial 30-day supply under paragraph (1) of subdivision (a) is not required.
							</html:p>
							<html:p>
								(c)
								<html:span class="EnSpace"/>
								A pharmacist dispensing an increased supply of a dangerous drug pursuant to this section shall notify the prescriber of the increase in the quantity of dosage units dispensed.
							</html:p>
							<html:p>
								(d)
								<html:span class="EnSpace"/>
								In no case shall a pharmacist dispense a greater supply of a dangerous
						drug pursuant to this section if the prescriber personally indicates, either orally or in their own handwriting, “No change to quantity,” or words of similar meaning. Nothing in this subdivision shall prohibit a prescriber from checking a box on a prescription marked “No change to quantity,” provided that the prescriber personally initials the box or checkmark. To indicate that an increased supply shall not be dispensed pursuant to this section for an electronic data transmission prescription as defined in subdivision (c) of Section 4040, a prescriber may indicate “No change to quantity,” or words of similar meaning, in the prescription as transmitted by electronic data, or may check a box marked on the prescription “No change to quantity.” In either instance, it shall not be required that the prohibition on an increased supply be manually initialed by the prescriber.
							</html:p>
							<html:p>
								(e)
								<html:span class="EnSpace"/>
								This section shall not apply to psychotropic medication or psychotropic drugs as described in subdivision (d) of Section 369.5 of the Welfare and Institutions Code.
							</html:p>
							<html:p>
								(f)
								<html:span class="EnSpace"/>
								Except for the provisions of subdivision (d), this section does not apply to contraceptives.
							</html:p>
							<html:p>
								(1)
								<html:span class="EnSpace"/>
								A pharmacist shall dispense, at a patient’s request, up to a 12-month supply of a contraceptive pursuant to a valid prescription that specifies an initial quantity followed by periodic refills.
							</html:p>
							<html:p>
								(2)
								<html:span class="EnSpace"/>
								A pharmacist furnishing a contraceptive pursuant to Section 4052.3 under protocols developed by the California State Board of Pharmacy
						may furnish, at the patient’s request, up to a 12-month supply at one time.
							</html:p>
							<html:p>
								(3)
								<html:span class="EnSpace"/>
								Nothing in this subdivision shall be construed to require a pharmacist to dispense or furnish a drug if it would result in a
						violation of Section 733.
							</html:p>
							<html:p>
								(g)
								<html:span class="EnSpace"/>
								Nothing in this section shall be construed to require a health care service plan, health insurer, workers’ compensation insurance plan, pharmacy benefits manager, or any other person or entity, including, but not limited to, a state program or state employer, to provide coverage for a dangerous drug in a manner inconsistent with a beneficiary’s plan benefit.
							</html:p>
						</ns0:Content>
					</ns0:LawSectionVersion>
				</ns0:LawSection>
			</ns0:Fragment>
		</ns0:BillSection>
	</ns0:Bill>
</ns0:MeasureDoc>